ABOUT
Company Profile
Founded in 2019, Calgent Biotechnology develops innovative oncology and immunology therapies that address unmet medical needs.
Our integrated R&D platform covering translational research, pharmacology, formulation, and clinical development accelerates drug discovery and development.
We combine proprietary programs with strategic in-licensing to build a robust pipeline and foster collaborative partnerships.
Guided by our core values of innovation, precision, and efficiency, we are committed to delivering transformative treatments with a long-term focus on age-related diseases and healthy aging.
Management Team
Chair of Board
Dr. Yun Yen MD, PhD
Education
- Taipei Med University (MD)
- Thomas Jefferson University (PhD)
- Yale University School of Medicine (Hem Onc Fellow)
Career Experience
- Over 40 years in translational medicine, oncology, and clinical practice
- Inventor on 80+ patents and author of over 400 scientific publications
- Held senior leadership roles including President of Taipei Medical University and Deputy Director at City of Hope National Medical Center
- Adjunct/Affiliate appointments at Caltech, Case Western Reserve University, Taipei Medical University, and Academia Sinica
- Fellow of the U.S. National Academy of Inventors
- Chair, Biomedical Division, Advanced Technology Advisory Committee, Industrial Technology Research Institute
- Member, Biotechnology Industry Strategy Advisory Committee
- Board Member, National Health Research Institutes and Tzu Chi Medical Foundation
CEO
Hui Wen Huang
Education
- E.M.B.A., Business Administration, National Taiwan University
Career Experience
- Over 25 years of executive leadership in the biomedical industry, spanning drug development, medical devices, healthcare management, and CRO operations
- Extensive expertise in regulatory strategy, IP, market analysis, and commercial valuation
- Former Director of Business Development at Taipei Medical University and General Manager of affiliated healthcare and pharmaceutical companies
- Senior leadership roles in CRO and pharmaceutical marketing
- Advisor to government agencies and national biotech parks on policy and strategic review
Independent Director at Lightek Corporation
CFO
Julian Huang
Education
- B.B.A., College of Management, Tamkang University
Career Experience
- Over 25 years of experience in accounting and financial management
- Former Group CFO at POJU Group Co., Ltd., CFO (Mainland China) at Kayee Group and Kayee Hotel Group, Manager at Rotam Global AgroSciences Co., Ltd., Representative at the Shanghai Office of Fubon Securities Co., Ltd., and Senior Project Manager at Grand Cathay Securities Co., Ltd.
Director of Business Development Dept.
Jenny Jang
Education
- M.S., Nutrition, Pennsylvania State University, USA
- M.S., Institute of Microbiology & Biochemistry, National Taiwan University
- B.S., Biochemical Science and Technology, National Taiwan University
Career Experience
- Over 20 years of business development experience in the biomedical sector
- Former Director of Business Development at Tanvex BioPharm, Head of Commercialization at Development Center for Biotechnology
- Held senior management roles at pharma and biotech companies including Gold NanoTech, Global Investment Holdings, NatureWise, and Orient EuroPharma
Deputy Director of Clinical Research & Operation Dept.
Jing Yi Lee
Education
- Ph.D., PharmacologySchool, National Yang-Ming University
Career Experience
- Over 11 years of experience in small molecule drug development for metabolic, dermatological, rare diseases, and oncology indications
- Experienced in clinical and non-clinical research, CRO management, and project oversight
- Led design and execution of Phase I/II clinical trials and key toxicology study audits
- Former Scientific Expert at Paraxel International and Associate Director of Medical Research at TWi Biotechnology
Director of CMC & Formulation Dept.
Yu Tsai Yang
Education
- Ph.D., School of Dentistry-Master and PhD Program, Taipei Medical University
Career Experience
- Over 16 years hands-on experience in formulation development, drug delivery technologies, and process development
- Specializes in oral delivery platforms for protein therapeutics; holder of multiple international patents
- Former Director of Drug Development at Innopharmax
- Post-doctoral Fellow, School of Pharmacy, University of North Carolina at Chapel Hill, USA
Director of Translational Research Dept.
Wan Fen Li
Education
- Ph.D., Toxicology, University of Washington, Seattle, WA, USA
Career Experience
- Over 15 years in toxicology research
- Over 11 years in new drug development including biologics and small molecule drugs
- Extensive experience in nonclinical pharmacology and toxicology research, clinical study design, and regulatory strategy
- Leadership roles in nonclinical pharm/tox team and drug development team at OBI Pharma, Inc.
- Acting assistant professor at University of Washington
- Assistant investigator at National Health Research Institutes
Director of Administration Management Dept.
Lu An
Education
- M.S., Biomedical Informatics, Taipei Medical University
Career Experience
- Over 18 years of experience in senior executive administration and strategic support, with strong cross-functional coordination and project execution skills
- Former administrative lead at Taipei Medical University Hospital (TMUH), overseeing operations in both the Health Management Center and Cell Therapy Center, with hands-on experience in preventive and regenerative medicine
- Skilled in system design, process optimization, resource integration, and executive-level support with proven agility and communication strengths
Scientific Advisory Board
Robert B. Diasio, M.D.
Mayo Clinic Cancer Center
James Mulé, PhD
Moffitt Cancer Center
Jacqueline Whang-Peng, M.D., Ph.D.
Academician, Academia Sinica, ROC
Robert B. Diasio, M.D.
Mayo Clinic Cancer Center
James Mulé, PhD
Moffitt Cancer Center
Jacqueline Whang-Peng, M.D., Ph.D.
Academician, Academia Sinica, ROC